Integra Lifesciences Holdings (IART) Acquisitions (2009 - 2018)

Integra Lifesciences Holdings (IART) has 10 years of Acquisitions data on file, last reported at -$53.4 million in Q4 2018.

• For the quarter ending Q4 2018, Acquisitions fell 105.25% year-over-year to -$53.4 million; the trailing twelve-month figure through Sep 2023 stood at -$53.4 million (changed N/A YoY), and the FY2019 full-year result was $30.5 million, up 214.25% from the prior year.
• Acquisitions retreated to -$53.4 million in Q4 2018, from -$4000.0 in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $1.0 billion in Q4 2017 to a low of -$53.4 million in Q4 2018.
• A 5-year average of $116.6 million and a median of $13.2 million in 2015 frame the typical range for Acquisitions.
• Peak annual rise in Acquisitions reached 225965.33% in 2017, while the deepest fall reached 19300.0% in 2017.
• Tracing IART's Acquisitions over 5 years: stood at $85.9 million in 2014, then tumbled by 75.99% to $20.6 million in 2015, then slumped by 102.18% to -$450000.0 in 2016, then soared by 225965.33% to $1.0 billion in 2017, then tumbled by 105.25% to -$53.4 million in 2018.
• Business Quant data shows IART's Acquisitions at -$53.4 million in Q4 2018, -$4000.0 in Q3 2018, and $21.0 million in Q2 2018.